0001209191-18-045591.txt : 20180806
0001209191-18-045591.hdr.sgml : 20180806
20180806181937
ACCESSION NUMBER: 0001209191-18-045591
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180802
FILED AS OF DATE: 20180806
DATE AS OF CHANGE: 20180806
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sachdev Amit
CENTRAL INDEX KEY: 0001406338
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 18995842
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-08-02
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001406338
Sachdev Amit
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, CRO
Common Stock
2018-08-02
4
M
0
2155
91.05
A
48817
D
Common Stock
2018-08-02
4
S
0
700
175.06
D
48117
D
Common Stock
2018-08-02
4
S
0
400
175.88
D
47717
D
Common Stock
2018-08-02
4
S
0
400
176.95
D
47317
D
Common Stock
2018-08-02
4
S
0
355
178.49
D
46962
D
Common Stock
2018-08-02
4
S
0
300
179.38
D
46662
D
Common Stock
2018-08-03
4
M
0
1942
86.52
A
48604
D
Common Stock
2018-08-03
4
S
0
1142
174.50
D
47462
D
Common Stock
2018-08-03
4
S
0
700
175.86
D
46762
D
Common Stock
2018-08-03
4
S
0
100
176.69
D
46662
D
Common Stock
882
I
401(k)
Common Stock
12215
I
Held in Trust
Stock Option (Right to Buy)
91.05
2018-08-02
4
M
0
2155
0.00
D
2026-02-01
Common Stock
2155
12932
D
Stock Option (Right to Buy)
86.52
2018-08-03
4
M
0
1942
0.00
D
2027-02-02
Common Stock
1942
19416
D
Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $175.06 (range $174.47 to $175.43).
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $175.88 (range $175.52 to $176.10).
Open market sales reported on this line occurred at a weighted average price of $176.95 (range $176.62 to $177.21).
Open market sales reported on this line occurred at a weighted average price of $178.49 (range $178.09 to $178.77).
Open market sales reported on this line occurred at a weighted average price of $179.38 (range $179.17 to $179.49).
Open market sales reported on this line occurred at a weighted average price of $174.50 (range $174.17 to $175.07).
Open market sales reported on this line occurred at a weighted average price of $175.86 (range $175.57 to $176.30).
The option vests in 16 quarterly installments from 2/2/2016.
The option vests in 16 quarterly installments from 2/3/2017.
/s/ Stephen Migausky, Attorney-in-Fact
2018-08-06